JAC Advance Access originally published online on June 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy 2004 54(2):406-409; doi:10.1093/jac/dkh334
JAC vol.54 no.2 © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
A novel extended-spectrum ß-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance
Institut für Infektionsmedizin, Zentrum für Klinisch-Theoretische Medizin I, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52, D-20246 Hamburg, Germany
* Corresponding author. Tel: +49-40-42803-3147; Fax: +49-40-42803-4881; Email: e.stuerenburg{at}uke.uni-hamburg.de
Objective: In recent years, cefotaximases of the CTX-M type have become a predominant cause of resistance to extended-spectrum cephalosporins in Gram-negative bacteria. Although most enzymes provide higher levels of resistance to cefotaxime than to ceftazidime, mutants with enhanced catalytic efficiency against ceftazidime have recently been described. This report identifies another ceftazidime-resistant mutant of the CTX-M class of enzymes.
Methods: Two ceftazidime-resistant strains, Escherichia coli IFI-1 and Klebsiella pneumoniae IFI-2, were isolated from a 46-year-old man during treatment of postoperative peritonitis with ceftazidime. Susceptibility testing, mating-out assays, isoelectric focusing as well as PCR and sequencing techniques were carried out to investigate the underlying mechanism of resistance.
Results: E. coli IFI-1 and K. pneumoniae IFI-2 exhibited a clavulanic acid-inhibited substrate profile that included extended-spectrum cephalosporins. Notably, both strains had up to a 32-fold higher level of resistance to ceftazidime than to cefotaxime. Further characterization revealed that a novel blaCTX-M gene encoding a ß-lactamase with a pI of 8.9 was implicated in this resistance: CTX-M-23. Along with the substitutions D114N and S140A, CTX-M-23 differed from CTX-M-1, the most closely related enzyme, by a P167T replacement in the active-site omega loop, which has not previously been observed in other CTX-M enzymes. By analogy with what was observed with certain TEM/PSE/BPS-type ß-lactamases, the amino acid substitution in the omega loop may explain ceftazidime resistance, which has only rarely been reported for other CTX-M enzymes.
Conclusion: The emergence of a new ceftazidime-resistant CTX-M-type mutant provides evidence that these enzymes are able to broaden their substrate spectrum towards ceftazidime, probably due to substitutions in the active-site omega loop.
Keywords: CTX-M ß-lactamases , ESBLs , cephalosporins
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Kiratisin, A. Apisarnthanarak, C. Laesripa, and P. Saifon Molecular Characterization and Epidemiology of Extended-Spectrum- {beta}-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Isolates Causing Health Care-Associated Infection in Thailand, Where the CTX-M Family Is Endemic Antimicrob. Agents Chemother., August 1, 2008; 52(8): 2818 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Novais, R. Canton, T. M. Coque, A. Moya, F. Baquero, and J. C. Galan Mutational Events in Cefotaximase Extended-Spectrum {beta}-Lactamases of the CTX-M-1 Cluster Involved in Ceftazidime Resistance Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2377 - 2382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Stepanova, M. Pimkin, A. A. Nikulin, V. K. Kozyreva, E. D. Agapova, and M. V. Edelstein Convergent In Vivo and In Vitro Selection of Ceftazidime Resistance Mutations at Position 167 of CTX-M-3 {beta}-Lactamase in Hypermutable Escherichia coli Strains Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1297 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. K. Bae, B. H. Lee, H. Y. Hwang, S. H. Jeong, S. G. Hong, C. L. Chang, H.-S. Kwak, H. J. Kim, and H. Youn A novel ceftazidime-hydrolysing extended-spectrum {beta}-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop J. Antimicrob. Chemother., August 1, 2006; 58(2): 315 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Delmas, F. Robin, F. Carvalho, C. Mongaret, and R. Bonnet Prediction of the Evolution of Ceftazidime Resistance in Extended-Spectrum {beta}-Lactamase CTX-M-9 Antimicrob. Agents Chemother., February 1, 2006; 50(2): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Paterson and R. A. Bonomo Extended-Spectrum {beta}-Lactamases: a Clinical Update Clin. Microbiol. Rev., October 1, 2005; 18(4): 657 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Delmas, F. Robin, F. Bittar, C. Chanal, and R. Bonnet Unexpected Enzyme TEM-126: Role of Mutation Asp179Glu Antimicrob. Agents Chemother., October 1, 2005; 49(10): 4280 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sturenburg, M. Lang, M. A. Horstkotte, R. Laufs, and D. Mack Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum {beta}-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria J. Antimicrob. Chemother., November 1, 2004; 54(5): 870 - 875. [Abstract] [Full Text] [PDF]
|
|